Delivery Order SPE2DB20D2104-SPE2DB22FU07M
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $9,215.11 for the supply of 4,564,158,437 units of Colchicine 0.6 mg capsules. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 4, 2024. The contract is a firm fixed-price type, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4562417372 COLCHICINE 0.6 MG CAPSULE 100S. The $4,430.97 Firm Fixed Price contract is a Delivery Order with an ultimate completion date of October 10, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a $1,017.74 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 100 tablets of Colchicine 0.6 mg, a medication used to treat gout. The delivery order has an ultimate completion date of July 10, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Colchicine 0.6 mg tablets in unit dose packaging (30-count configuration). This firm fixed-price delivery order, valued at $2,916.78, is scheduled for completion by December 30, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COLCHICINE 0.6 MG TABLET 100S, with a ceiling value of $1,358.53 and a period of performance extending to May 30, 2025. The contract is not set-aside and was awarded on May 29, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Colchicine tablets, with a contract ceiling value of $2,793.54. This firm fixed-price delivery order is scheduled for completion by December 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside, competitively awarded contract and is a child order under a larger contract vehicle. This...
- The Defense Logistics Agency awarded a $340,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 boxes containing 0.6 mg colchicine tablets. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order from its corporate office located in Conshohocken, Pennsylvania, with performance required between July 18-19, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the global supply...
- The Defense Logistics Agency awarded a $307 firm fixed price delivery order to Amerisourcebergen Drug Corp for 4561563840 colchicine 0.6 mg capsules. Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, will deliver 30 capsules to a location in Conshohocken, Pennsylvania by July 24, 2023 to fulfill requirements under this order. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military services and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,700.07 firm fixed-price delivery order is for the supply of Colcrys 0.6 mg tablets, a medication used to treat gout and familial Mediterranean fever. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,558.53 placed by the Defense Logistics Agency (DLA) for the supply of COLESTID 1 GM TABLET 120S. The award has an ultimate completion date of October 10, 2023 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FU07MDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $23,833.44 firm fixed-price delivery order is for 4,558,615,825 units of the drug Colchicine 0.6 mg capsules. The award has an ultimate completion date of September 28, 2022 and is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, with a focus on supporting the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities and veteran healthcare programs globally. This delivery order is issued under that larger IDC contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.8k | 9/27/22 |